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Abstract
Background/Objective: To determine the pattern of eclampsia and its contribution to maternal mortality
at the Federal Medical Centre, Birnin Kudu, Jigawa State in Northern Nigeria.
Method: A 4-year retrospective review of the case records of all women who presented with eclampsia at
the center. All the case records were retrieved from the medical record department and analyzed.
Results: There were 207 cases of eclampsia out of 2197 deliveries during the period giving an incidence
of 9.42%. 171(82.6%) of the patients were unbooked. Majority (58.5%) of the patients were aged less
than 20 years. The highest frequency (78.3%) was recorded in the primigravida. Delay before reaching
the hospital was established in 116(56%) of patients. The condition was antepartum in 68(32.9%),
intrapartum in 112(54.1%) and postpartum in 27(13%). 107(51.7%) of the patients were delivered by
cesarean section. Twenty two (10.6%) of the mothers died. Eclampsia was the commonest cause of
maternal mortality and contributed 43.1% of all maternal deaths. 180(87%) of the babies were delivered
alive while 27(13%) died.
Conclusion: Eclampsia is a major cause of maternal mortality. There is need for health education on the
need for patients to avail themselves of antenatal care.
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Résumé
Fond/Objectif: Pour détermine la distribution de l’éclampsie et sa contribution a la mortalité maternelle
au centre de santé médical fédéral de Birnin Kudu, état de Jigawa au Nord du Nigeria.
Méthodologie: Ceci est une revue rétrospective pendant quatre ans des cas reportes de toutes les femmes
qui se sont présentées avec l’éclampsie a ce centre. Tous ces rapports ont été obtenu au département des
rapports médicaux et ont été analyses.
Résultats: Il y a eu 207 cas d’éclampsie permis 2197 naissances. Ceci donne une incidence de 9.42%.
171 (82.6%) de tous ces patients n’ont pas fait de visite prénatale. La majorité des patients (58.5%)
étaient ages de moins de 20 ans. La fréquence la plus élevée (78.3%) a été obtenu parmi les primigravid.
Le retard avant de se présenter au centre de santé a été étable chez 116 (56%) des patients. La condition
était prénatale chez 68 (32.9%), intra natale chez 112 (54.1%) et postnatale chez 27 (13%). Chez 107
(51.7%) patients, l’accouchement s’est fait par caesarienne. 22 (10.6%) de maman étaient decedees.
L’éclampsie était la cause de la mortalité maternelle la plus élevée et a contribue a 43.1% de tous les
décès maternels. 180(87%) bébés sont nés vivant alois que 27(13%) étaient mort nes.
Conclusion: L’éclampsie est la cause majeure de la mortalité maternelle. Les patients ont besoin d’être
éduques et aussi d’aller aux visites prénatales.
Mots clés: Éclampsie, Mortalité maternelle
Introduction
Eclampsia is a common cause of maternal mortality
worldwide but particularly in the developing
countries. It is estimated that every year eclampsia is
associated with about 50 000 maternal deaths
worldwide, most of which occur in developing
countries.1 A study done in 2004 to assess the status
of emergency obstetric care in the different zones of
Nigeria by the Society of Gynaecology and Obstetrics
of Nigeria (SOGON) revealed eclampsia as a major
contributor to maternal mortality in the whole
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country. In Kano State (which is in the same zone as
the place where this study was conducted), eclampsia
was not only the commonest cause of maternal
mortality but also contributed 46.3% of all the
maternal deaths in one study2 and 31.3% in another.3
Reports from other centers especially in northern
Nigeria also reveal a similar picture of high incidence
of eclampsia and contribution to maternal mortality.4,5
In the developing countries, there is low
utilization of both antenatal and intrapartum care and
the patients may present to the hospital only as a last
resort. The opportunity to detect women at the pre-
eclamptic phase is therefore usually lost. In addition,
the World Health Organisation (WHO) estimates that
only 40% of births in developing countries take place
in health facilities.6 When delivery care is sought, it is
done late, after a lot of delays and this contributes to
maternal mortality. Yet, prenatal care and supervision
of delivery by trained birth attendants are said to be
the best and cost-effective means of reducing
maternal and perinatal mortality and morbidity.7,8
Even for those women who eventually make
it to the hospital, they may be attended to in facilities
with shortage of staff, equipment and/or drugs.
Despite evidence that magnesium sulfate is the most
effective anticonvulsant for the prevention and
treatment of eclampsia9,10 and it has been used in the
developing countries and shown to have a favorable
maternal and fetal outcome,11,12 it has remained
unavailable in most centers.
The current study was done to determine the
clinical presentation of eclampsia, its management, as
well as maternal and fetal complications in patients
who presented at Federal Medical Center Birnin
Kudu, Jigawa state.
Materials and Methods
This is a descriptive study of all consecutive patients
with eclampsia managed at the Federal Medical
Centre, Birnin Kudu between 1st January 2002 and
31st December 2005. Birnin Kudu is a semi urban
area located in the savannah region of Northern
Nigeria. The hospital is a rural health facility
undergoing transformation from a secondary to
tertiary facility. It is also a referral center for patients
from the neighboring states of Kano and Bauchi.
Autopsy was not offered in the facility due to lack of
expertise. Eclamptics are generally managed by
sedation with intravenous diazepam, treatment of
severe hypertension with intravenous hydrallazine and
delivering the baby through the safest and fastest
means. Magnesium sulfate was not available for use
during the period under review.
The case notes of all the patients were
retrieved from the Medical Record Department and
analyzed. The data obtained included age, parity,
ethnic group, booking status (registered for antenatal
care and had at least two visits with one of the visits
within the last two weeks before delivery), place of
delivery, delay before reaching the hospital, type of
eclampsia, modality of delivery and the maternal and
fetal outcome. The data was analyzed by the use of
EPI INFO statistical software version 3.3.2.
Comparison of variables was by the student t test with
statistically significant value set at p-value <0.05.
Results
There were two hundred and seven (207) patients that
presented with eclampsia out of 2197 deliveries
during the period giving an incidence of 9.42%. One
hundred and seventy one (82.6%), of the patients were
unbooked. The age and parity distribution are shown
in Table 1. Majority (58.5%) of the patients were aged
less than 20 years (range of 15-49). The highest
frequency (78.3%) was recorded in the primigravida
(mean parity was 0.8 standard deviation of 2.1). Delay
in reaching medical facility (defined as inability to
reach the hospital from home within three hours) was
established in 116 (56%) of patients. From the
records, it was however not possible to determine
those who had delays after arrival at the facility
before accessing care. One hundred and twenty five
(60.4%) of the patients premonitory symptom in the
form of headache, epigastric pain and/or blurring of
vision. The mean number of fits before admission was
5 (range of 1-11; standard deviation 3.6). The clinical
type of eclampsia was intrapartum in 112 (54.1%),
antepartum in 68 (32.9%) and postpartum in 27 (13%)
of the patients. One hundred and seven (51.7%) of the
patients were delivered by cesarean section while the
others had vaginal delivery assisted with vacuum or
forceps. For those mothers delivered by cesarean
section, there were 95(88.7%) live babies delivered
while for those who had assisted vaginal delivery,
there were 85(85%) live babies delivered. The
difference was not statistically significant (P>.05).
Table 1. Distribution of patients by age and parity
Age group Parity Total
0 1 2 3 4 ≥5
13-19 113 8 0 0 0 0 121
20-29 46 9 2 2 7 4 70
30-39 2 0 2 1 0 5 10
40-49 1 0 1 0 0 4 6
Total 162 17 5 3 7 13 207
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Twenty two (10.6%) of the patients died. All
the deaths were recorded in unbooked patients. This
association of mortality with failure to book for
antenatal care was statistically significant (P<.05).
Among the patients that died, delay was demonstrated
among 18 (81.8%) of them and this was statistically
significant (P<.05). During the period under review
fifty one maternal deaths were recorded (Table 2).
Eclampsia was the commonest cause of maternal
mortality during the period, contributing 22 (43.1%)
of the deaths. One hundred and eighty (87%) of the
babies were delivered alive while 27 (13%) died
within one week of delivery. There was only one case
of twin pregnancy while the rest were singleton.
Table 2. Causes of Maternal Mortality at Federal




Obstructed labor 5 9.8
Antepartum hemorrhage 4 7.8
Postpartum hemorrhage 4 7.8
Puerperal sepsis 4 7.8
Ruptured uterus 3 5.9
Hepatitis 1 2.0
Meningitis 1 2.0
Chronic liver disease 1 2.0
Total 51 100
Discussion
The incidence of eclampsia in this study was 9.42%.
This was higher than that reported from Kaduna
(0.42%),4 Sokoto (4.29%),5 Nnewi (0.75%),13 all in
Nigeria and also Kathmandu, Nepal (0.29%).14 The
higher prevalence in this study is probably as a result
of two major reasons. First, was the rather low use of
antenatal services. Majority of the patients (82.6%)
never utilized any form of antenatal care throughout
the pregnancy. If they had benefited from antenatal
care, pre-eclampsia could have been detected and
some form of treatment offered before the disease
progressed to eclampsia. This may include stopping
the pregnancy by induction or cesarean section.
Second, our patients had tendency to delay reaching
the health facility as this was demonstrated in 56% of
them.
Eclampsia was noted to be commoner among
the young primigravida patients. This finding is
consistent with that of other studies.4,5,13 The
importance of this finding is that this group of patients
deserve extra surveillance during antenatal care in
terms of monitoring their blood pressure and
screening their urine for proteinuria to detect pre-
eclampsia.
Delay in reaching the health facility was
recorded in 56% of the patients. It is therefore not
surprising that the mean number of fits in the patients
was 5. It is not clear from the records if there were
other patients who may have had delays at the facility
before accessing care. The delay in accessing medical
care and the high number of fits prior to medical
intervention could have contributed to the rather high
mortality of 10.6% of the patients. Eclampsia was the
commonest cause of maternal mortality for the period.
The case fatality rate of 10.6% due to eclampsia is
comparable to the 9.3% reported from Nnewi13 and
11.6% reported from Gombe.15 The finding that
eclampsia was responsible for 43.1% of all the
maternal deaths recorded in the Centre is also similar
to the 46.1% in Kano State as recorded in the SOGON
study.2 Jigawa and Kano states share common borders
and their people’s culture and beliefs. The perinatal
mortality rate was 130/1000 deliveries. This was
lower than the 368/1000 deliveries reported from
Gombe15 and 409/1000 reported from Kaduna.16
This study confirms that eclampsia is still a
major cause of maternal and perinatal mortality in our
environment. A major association appears to be lack
of utilization of antenatal care and delay at accessing
skilled care during delivery. To address this problem,
there is need for community health education to
increase the awareness of pregnant women to avail
themselves of antenatal care and safe delivery in the
nearest health post. Reduction on poverty and
improvement of the socio economic condition of the
citizens will make them afford health care. The
National Health Insurance Scheme has been
introduced by the Nigerian government. It is a form of
contributory social security and offers health care that
is acceptable and affordable to the community. It
needs to be extended to reach the rural areas so that
the poor ones can access care. There is need to
improve roads, transportation as well as
communications.
With the recent establishment of intensive
care facilities for adults and babies in the Center, it is
will be interesting to evaluate such intervention on the
morbidity and mortality of mothers and their babies in
the near future. Furthermore, the construction of a
new antenatal clinic and an operation theater for the
exclusive use of operative deliveries is at the final
stage of completion. It is hoped that such
interventions will have positive impact on maternal
and child care. It is noted that the Nigerian
government has focused its attention to these issues in
the Millennium Development Goals (MDG) it set to
achieve by the target date of 2015.17 At the time of
writing this report efforts are being made to procure
and make magnesium sulfate available for use in the
treatment of eclampsia in consideration of its
superiority over diazepam.
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